Compare Humana Inc (HUM) vs Meta Platforms Inc (META) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Meta Platforms Inc — how do they compare? Humana Inc trades at $404.89 (market cap $47.81B), while Meta Platforms Inc trades at $647.27 (market cap $1.64T). The key difference: Meta Platforms Inc is far larger — about 34.3× Humana Inc's market cap, and Humana Inc pays the higher dividend (0.89%). Which is the better fit depends on your goals.
| HUM | META | |
|---|---|---|
Market Cap | $47.81B | $1.64T |
Sector | Health | Media |
52-Week High | $409.42 | $790.00 |
52-Week Low | $163.67 | $525.72 |
Enterprise Value | $56.85B | $1.65T |
Dividend Yield | 0.89% | 0.33% |
Volume | — | 24,093,972 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
META stock trades at $646.96, up 0.15% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong earnings beats in recent quarters, including Q1 2026 EPS of $10.44 versus $6.70 expected, driven by robust revenue growth and a net income margin of 32.84%. Recent developments include the launch of the Muse Spark AI model and a dividend payment scheduled for June 2026.
The outlook remains positive with analyst consensus pointing to a $817.32 price target and 79% buy ratings. Key opportunities include AI innovation and revenue expansion, while risks involve regulatory lawsuits and high capital expenditures. The stock's valuation at a P/E of 23.49 appears reasonable given growth prospects, but investors should monitor legal and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Meta Platforms Inc
Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.
Read more on META →
